A prospective randomized study of adjuvant chemotherapy with navelbine [vinorelbine] and cisplatin in completely resected non small cell lung cancer

Trial Profile

A prospective randomized study of adjuvant chemotherapy with navelbine [vinorelbine] and cisplatin in completely resected non small cell lung cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Jul 2009

At a glance

  • Drugs Cisplatin; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms ANITA-01
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 31 Jul 2009 Preliminary BRAC1 analyses have been presented at the 13th World Conference on Lung Cancer.
    • 31 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top